References
- Abrams, T. (2003). Warning Letter [Press release]. Retrieved from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM168946.pdf.
- Barrett, J. (2016). DEA Reduces Opioid Manufacturing in 2017. Retrieved from http://www.pharmacytimes.com/news/dea-reduces-opioid-manufacturing-for-2017
- Barry, D. T., Pilver, C. E., Hoff, R. A., & Potenza, M. N. (2013). Pain interference and incident mood, anxiety, and substance-use disorders: Findings from a representative sample of men and women in the general population. Journal of Psychiatric Research, 47(11), 1658–1664. doi: 10.1016/j.jpsychires.2013.08.004
- Boards, S. M. (2001). Model Policy for the Use of Controlled Substances for the Treatment of Pain. Retrieved from http://dpr.delaware.gov/boards/medicalpractice/documents/Model_Policy_Treatment_Pain.pdf.
- Booth, M. (1999). Opium: A History. New York: St. Martin’s Griffin.
- CDC (2016). Wide-ranging online data for epidemiologic reserach (WONDER). Retrieved March 31, 2017, from National Center for Health Statistics http://wonder.cdc.gov
- CDC.gov. (2016). Opioid Overdose-Opioid Basics: Understanding the Epidemic. Retrieved from https://www.cdc.gov/drugoverdose/epidemic/index.html#
- CDC/NCHS (2016). National Vital Statistics System, Mortality
- Cicero, T. J., & Ellis, M. S. (2015). Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from oxycontin. JAMA Psychiatry, 72(5), 424–430. doi: 10.1001/jamapsychiatry.2014.3043
- Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826. doi: 10.1001/jamapsychiatry.2014.366
- Connors, A. F., Dawson, N. V., Desbiens, N. A., Fulkerson, W. J., Goldman, L., Harrell, F. E., ... Wenger, N. S. (1996). Erratum: A controlled trial to improve care for seriously ill hospitalized patients: The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT) (Journal of the American Medical Association (November 22/29, 1995) 274 (1591–1598)). Journal of the American Medical Association, 275(16), 1232. doi: 10.1001/jama.275.16.1232
- Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241–248. doi: 10.1056/NEJMsa1406143
- Daubresse, M., Chang, H.-Y., Yu, Y., Viswanathan, S., Shah, N. D., Stafford, R. S., … Alexander, G. C. (2013). Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000–2010. Medical Care, 51(10), 870–878. doi: 10.1097/MLR.0b013e3182a95d86
- DEA proposes reduction to amount of controlled substances to be manufactured in 2018 (2017). Online: DEA Public Affairs Retrieved from https://www.dea.gov/divisions/hq/2017/hq080417.shtml.
- Definitions Related to the Use of Opioids for the Treatment of Pain (2001). Retrieved from The American Academy of Pain Medicine, The American Pain Society and the American Society of Addiction Medicine: Consensus Document https://www.fda.gov/ohrms/dockets/ac/03/briefing/3978B1_07_B-FDA-Tab%206.pdf
- Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain–United States, 2016. JAMA, 315(15), 1624–1645. doi: 10.1001/jama.2016.1464
- Duarte, D. F. (2005). Uma breve história do ópio e dos opióides. Revista Brasileira de Anestesiologia, 55, 135–146.
- Fine, P. G. (2011). Long-term consequences of chronic pain: Mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Medicine, 12(7), 996–1004. doi: 10.1111/j.1526-4637.2011.01187.x
- Garner, A. (2014). "FEAR Narcotic Drugs!" The Passage of the Harrison Act. Retrieved from https://nyamcenterforhistory.org/2014/12/17/fear-narcotic-drugs-the-passage-of-the-harrison-act/
- Gaskin, D. J., & Richard, P. (2012). The economic costs of pain in the United States. Journal of Pain, 13(8), 715–724. doi: 10.1016/j.jpain.2012.03.009
- Gerrits, M. M., van Oppen, P., van Marwijk, H. W., Penninx, B. W., & van der Horst, H. E. (2014). Pain and the onset of depressive and anxiety disorders. Pain, 155(1), 53–59. doi: 10.1016/j.pain.2013.09.005
- Hassett, A. L., Aquino, J. K., & Ilgen, M. A. (2014). The risk of suicide mortality in chronic pain patients. Current Pain and Headache Reports, 18(8), 436. doi: 10.1007/s11916-014-0436-1
- Huecker, M. R., & Shoff, H. W. (2014). The law of unintended consequences: Illicit for licit narcotic substitution. Western Journal of Emergency Medicine, 15(4), 561–563. doi: 10.5811/westjem.2014.3.21578
- Johannes, C. B., Le, T. K., Zhou, X., Johnston, J. A., & Dworkin, R. H. (2010). The prevalence of chronic pain in United States adults: Results of an Internet-based survey. Journal of Pain, 11(11), 1230–1239. doi: 10.1016/j.jpain.2010.07.002
- Johnson, S. (2016, June 15). AMA seeks move toward opioid alternatives. Retrieved from http://www.modernhealthcare.com/article/20160615/NEWS/160619941
- Jones, C. M. (2013). Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002–2004 and 2008–2010. Drug Alcohol Depend, 132(1–2), 95–100.
- Kapoor, L. (1997). Opium Poppy: Botany, Chemistry, and Pharmacology. Binghamton, NY: The Hawworth Press, Inc.
- Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574. doi: 10.1146/annurev-publhealth-031914-122957
- Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., … Noorbaloochi, S. (2018). Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: The SPACE Randomized Clinical Trial. JAMA, 319(9), 872–882. doi: 10.1001/jama.2018.0899
- Kritikos, P., & Papadaki, S. (1967). The history of the poppy and of opium and their expansion in antiquity in the Eastern Meditteranean area. Bulletin of Narcotics, 19(3), 17–38.
- Martino, A. M. (1998). In search of a new ethic for treating patients with chronic pain: What can medical boards do? The Journal of Law, Medicine & Ethics, 26(4), 332–349. doi: 10.1111/j.1748-720X.1998.tb01679.x
- Max, M. B. (1990). Improving outcomes of analgesic treatment: Is education enough?. Annals of Internal Medicine, 113(11), 885–889. doi: 10.7326/0003-4819-113-11-885
- MCCoy, A. W. (2003). The politics of heroin: CIA complicity in the global drug trade, Afghanistan, Southeast Asia, Central America, Colombia (Revised Edition) (2nd ed.). Chicago, Illinois: Lawrence Hill Books.
- McWilliams, L. A., Cox, B., J., & Enns, M. W. (2003). Mood and anxiety disorders associated with chronic pain: An examination in a nationally representative sample. Pain, 106(1–2), 127–133.
- Moghe, S. (2016, October 14). Opioid history: From ‘wonder drug’ to abuse epidemic. Retrieved from https://www.cnn.com/2016/05/12/health/opioid-addiction-history/index.html
- Morris, D. (1991). The culture of pain [Press release]
- Muhuri, P. K., & Davies, C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. Retrieved from https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm
- National Pharmaceutical Council. (2001). Pain: Current understanding of assessment, management, and treatments. Retrieved from http://www.npcnow.org/system/files/research/download/Pain-Current-Understanding-of-Assessment-Management-and-Treatments.pdf
- National Hospital Ambulatory Medical Care Survey (2006). National Hospital Ambulatory Medical Care Survey https://www.cdc.gov/nchs/ahcd/about_ahcd.htm
- Nicol, A. L., Hurley, R. W., & Benzon, H. T. (2017). Alternatives to opioids in the pharmacologic management of chronic pain syndromes: A narrative review of randomized, controlled, and blinded clinical trials. Anesthesia & Analgesia, 125(5), 1682–1703. doi: 10.1213/ANE.0000000000002426
- Pawl, R. (2008). Prescription narcotic drug abuse: “We have met the enemy and they are ourselves.”. Surgical Neurology, 69(5), 538–541. doi:http://dx.doi.org/10.1016/j.surneu.2007.10.013
- Pellegrino, E. D. (1998). Emerging ethical issues in palliative care. JAMA, 279(19), 1521–1522.
- Portenoy, R. K. (1996a). Opioid therapy for chronic nonmalignant pain: A review of the critical issues. Journal of Pain and Symptom Management, 11(4), 203–217.
- Portenoy, R. K. (1996b). Opioid therapy for chronic nonmalignant pain: Clinician's perspective. Journal of Law, Medicine & Ethics, 24(4), 296–309.
- Prescription Drugs: OxyContin Abuse and Diversion and Efforts to Address the Problem. (2003). Retrieved from Washington, DC: General Accounting Office.
- Rich, B. A. (2000). An ethical analysis of the barriers to effective pain management. Cambridge Quarterly of Healthcare Ethics, 9(1), 54–70.
- Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. Morbidity and Mortality Weekly Report, 65(5051), 1445–1452. doi: 10.15585/mmwr.mm655051e1
- Rustoen, T., Wahl, A. K., Hanestad, B. R., Lerdal, A., Paul, S., & Miaskowski, C. (2005). Age and the experience of chronic pain: Differences in health and quality of life among younger, middle-aged, and older adults. Clinical Journal of Pain, 21(6), 513–523.
- Santayana, G. (1921). The life of reason: Introduction and reason in common sense. Prometheus Books. Volume VII, Book One. Cambridge, Massachusetts, and London, England: The MIT Press.
- Shah, A., Hayes, C. J., & Martin, B. C. (2017). Characteristics of initial prescription episodes and likelihood of long-term opioid use – United States, 2006-2015. Morbidity and Mortality Weekly Report, 66(10), 265–269. doi: 10.15585/mmwr.mm6610a1
- Shmagel, A., Foley, R., & Ibrahim, H. (2016). Epidemiology of chronic low back pain in US adults: Data From the 2009–2010 National Health and Nutrition Examination Survey. Arthritis Care Research (Hoboken), 68(11), 1688–1694. doi: 10.1002/acr.22890
- The NSDUH Report: Substance Use and Mental Health Estimates from the 2013 National Survey on Drug Use and Health: Overview of Findings. (2014). Retrieved from Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD.
- Tompkins, D. A., Hobelmann, J. G., & Compton, P. (2017). Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma. Drug and Alcohol Dependence, 173 (Suppl 1), S11–S21. doi: 10.1016/j.drugalcdep.2016.12.002
- Tracy, S. W., & Acker, C. J. (Eds.). (2004). Altering American Consciousness: The history of alcohol and drug use in the United States, 1800–2000. Amherst and Boston: University of Massachusetts Press.
- Trickey, E. (2018). Inside the Story of America’s 19th Centruy Opiate Addiction, Retrieved from https://www.smithsonianmag.com/history/inside-story-americas-19th-century-opiate-addiction-180967673/
- Tsang, A., Von Korff, M., Lee, S., Alonso, J., Karam, E., Angermeyer, M. C., … Watanabe, M. (2008). Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. Journal of Pain, 9(10), 883–891. doi: 10.1016/j.jpain.2008.05.005
- UNODC (2008). 2008 World Drug Report. Retrieved from Vienna, Austria: https://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf
- Van Zee, A. (2009). The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. American Journal of Public Health, 99(2), 221–227. doi: 10.2105/AJPH.2007.131714
- Veehof, M. M., Oskam, M. J., Schreurs, K. M., & Bohlmeijer, E. T. (2011). Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis. Pain, 152(3), 533–542. doi: 10.1016/j.pain.2010.11.002
- Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain–misconceptions and mitigation strategies. New England Journal of Medicine, 374(13), 1253. 1263. doi: 10.1056/NEJMra1507771
- Wanzer, S. H., Federman, D. D., Adelstein, S. J., Cassel, C. K., Cassem, E. H., … Cranford, R. E. (1989). The physician's responsibility toward hopelessly ill patients. A second look. New England Journal of Medicine, 320(13), 844–849. doi: 10.1056/NEJM198903303201306